Jakub Hlávka is a doctoral candidate at the Pardee RAND Graduate School and an assistant policy researcher at RAND. His research addresses R&D investment by the public and private sector; the impacts of innovation in health care; and the theory and practice of national security. Since joining RAND, he has contributed to studies for NASA, the Office of the Secretary of Defense, Department of Health and Human Services, and other national and international clients.
In his dissertation, Hlávka studies innovative financing approaches for high-cost medical treatments like cell and gene therapies. He has also conducted a doctoral internship at Genentech where he assisted in R&D portfolio planning and has been a visiting fellow in health economics at the USC Schaeffer Center for Health Policy & Economics.
Prior to joining RAND, Hlávka served in research and consulting roles at the Fraunhofer Society in Germany, at RAND Europe in the UK and Belgium, and at the Czech Government and the Ministry of Finance in Prague. He has worked on intellectual property regulation, defense and aerospace industry trade, 3D printing, fight against corruption and the regulation of capital markets.
Hlávka received a master's degree from Georgetown University School of Foreign Service, specializing in international security and technology policy, and an undergraduate degree in international trade from the University of Economics in Prague. He has also joined the Hoover Institution at Stanford University and the Prague Security Studies Institute as a regulatory and security policy scholar. He is fluent in Czech, English, German and French.
Jakub Hlávka, "Portfolio Society: On the Capitalist Mode of Prediction. By Ivan Ascher," Science and Public Policy, 2017 (forthcoming)